Currently, there are 227.48M common shares owned by the public and among those 225.15M shares have been available to trade.
The company’s stock has a 5-day price change of -32.52% and -18.79% over the past three months. VXRT shares are trading -23.95% year to date (YTD), with the 12-month market performance down to -64.29% lower. It has a 12-month low price of $0.52 and touched a high of $1.54 over the same period. VXRT has an average intraday trading volume of 1.70 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -29.27%, -28.65%, and -32.15% respectively.
Institutional ownership of Vaxart Inc (NASDAQ: VXRT) shares accounts for 22.47% of the company’s 227.48M shares outstanding.
It has a market capitalization of $114.54M and a beta (3y monthly) value of 1.65. The earnings-per-share (ttm) stands at -$0.41. Price movements for the stock have been influenced by the stock’s volatility, which stands at 13.13% over the week and 8.78% over the month.
Earnings per share for the fiscal year are expected to increase by 32.16%, and 1.72% over the next financial year. EPS should shrink at an annualized rate of 8.97% over the next five years, compared to 27.81% over the past 5-year period.
Looking at the support for the VXRT, a number of firms have released research notes about the stock. Oppenheimer stated their Outperform rating for the stock in a research note on August 15, 2024, with the firm’s price target at $4. Jefferies coverage for the Vaxart Inc (VXRT) stock in a research note released on December 29, 2021 offered a Buy rating with a price target of $12. Cantor Fitzgerald was of a view on November 02, 2021 that the stock is Overweight, while B. Riley Securities gave the stock Neutral rating on June 29, 2021, issuing a price target of $13- $9. Jefferies on their part issued Buy rating on June 24, 2021.
